Brian Corvese - 25 Mar 2024 Form 4 Insider Report for Protagenic Therapeutics, Inc.\new (PTIX)

Role
Director
Signature
/s/ Christine Klaskin, Attorney-in-Fact
Issuer symbol
PTIX
Transactions as of
25 Mar 2024
Transactions value $
$76,125
Form type
4
Filing time
29 Mar 2024, 21:29:10 UTC
Previous filing
05 Mar 2024
Next filing
05 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTIX PTIX Common stock Options Award $76.1K +43.8K $1.74 43.8K 25 Mar 2024 PTIX Common Stock, Par Value $0.0001 43.8K $1.74 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

The options vest monthly over 24 months, commencing upon the date of grant, with full acceleration upon a change of control.